Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ahmed Ashour Badawy"'
Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients
Autor:
Amr Elkholy, Nagavardhini Avuthu, Mohammed Abdalla, Michael Behring, Prachi Bajpai, Hyung-Gyoon Kim, Doaa Header, Reham AH. Abo Elwafa, Hesham Saed, Amira Embaby, Nefertiti El-Nikhely, Sarah Obuya, Mostafa Mohamed, Ahmed Ashour Badawy, Ahmed Nawar, Farrukh Afaq, Laura Q. Rogers, Sejong Bae, James M. Shikany, Lori Brand Bateman, Mona Fouad, Mansoor Saleh, Temesgen Samuel, Sooryanarayana Varambally, Chittibabu Guda, Waleed Arafat, Upender Manne
Publikováno v:
Heliyon, Vol 9, Iss 7, Pp e18035- (2023)
Purpose: Although there is an established role for microbiome dysbiosis in the pathobiology of colorectal cancer (CRC), CRC patients of various race/ethnicities demonstrate distinct clinical behaviors. Thus, we investigated microbiome dysbiosis in Eg
Externí odkaz:
https://doaj.org/article/010f8a89f7864569b6c37779a74d7287
Publikováno v:
2020 11th International Renewable Energy Congress (IREC).
Today almost all the devices used around the world are powered by electrical energy either as a sole source or contributing in the system, moreover some applications requires a continuous electrical power source and the blackout might cause catastrop
Publikováno v:
The International Conference on Applied Mechanics and Mechanical Engineering. 18:1-9
The Space Situational Awareness (SSA) problem is becoming an exponentiallysignificant concern for satellite operators. The threat of on-orbit collisions endangerssatellites, spacecrafts and astronauts themselves especially in low-earth orbits(LEO). M
Publikováno v:
Journal of Cancer Therapy. :314-322
Background: Randomized clinical trials have demonstrated the benefits of chemotherapy in carefully selected non-small cell lung cancer (NSCLC) patients. How generalizable these results are to other NSCLC patients is unresolved. Methods: The outcomes
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: Advanced stage non-small cell lung cancer (NSCLC) is a heterogenous disease, yet, with the exception of targeted therapies, most guidelines recommended uniform treatment irrespective of tumor burden or sites of metastases and this may exp
Publikováno v:
Journal of Thoracic Oncology. 13:S867-S868
Publikováno v:
Journal of Thoracic Oncology. 12:S908
Publikováno v:
Annals of Oncology. 27:vi36
Publikováno v:
Journal of Clinical Oncology. 34:e20657-e20657
e20657Background: Advanced non-small cell lung cancer (NSCLC) is a worldwide problem. Despite widespread availability of multiple chemotherapies for stage IV NSCLC, response rates are generally low...
Publikováno v:
Journal of Clinical Oncology. 34:e20661-e20661
e20661Background: Despite the wide availability of many chemotherapeutic regimens for the treatment of advanced non-small cell lung cancer (NSCLC), by design most clinical trials compare a treatmen...